---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-060128"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2024-07-09T23:59:59+00:00"
generated_at: "2026-05-31T22:38:00.245971+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# BiomX shareholders OK 750M authorized shares, reverse split up to 1:10

## Summary
- Authorized common shares increased from 120M to 750M, a 6.25x expansion.
- Board authorized reverse stock split at ratio 1:5 to 1:10, effective before July 9, 2025.
- A&R 2019 LTIP approved with 78M shares initial reserve plus annual 4% evergreen.
- Conversion of 256,887 Series X Preferred shares and related warrants into common approved.
- Alan Moses and Edward Williams elected as Class I directors until 2027 annual meeting.

## SEC filing metadata
- accession: 0001213900-24-060128
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2024-07-09T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.02, 5.07, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000121390024060128/0001213900-24-060128-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000121390024060128/ea0209083-8k_biomx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-060128
- JSON: https://secwatch.observer/filing/0001213900-24-060128.json
- Plain text: https://secwatch.observer/filing/0001213900-24-060128.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.